Cytotoxic and apoptosis-inducing effects of bendamustine used alone and in combination with rituximab on chronic lymphocytic leukemia cells in vitro

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2014, Vol 68, Issue

Abstract

Aim: The aim of our study was to compare the cytotoxic effects of bendamustine (BENDA) and rituximab (RIT) used either alone or in combination and to evaluate the influence of the above mentioned drugs on apoptosis measured as changes in mitochondrial transmembrane potential (Δψm), expression of caspases and selected apoptosis-regulating proteins in freshly isolated peripheral blood mononuclear cells of chronic lymphocytic leukemia (CLL) patients. Material/Methods: Cytotoxic effect of tested drugs, as well as induction of apoptosis, drop in Δψm and expression of selected proteins involved in regulation of apoptosis were assessed in 48 hour cultures containing autologous serum (AS) using flow cytometry. BENDA was used at the concentration of 40 µg/ml and RIT at the concentration of 10 µg/ml. Control cultures were incubated without drugs. Results: BENDA used either alone or in combination with RIT strongly induced apoptosis as well as enhanced expression of selected apoptotic proteins, especially those involved in the intrinsic apoptotic pathway: P53, PUMA and BAX, which cause mitochondrial transmembrane potential changes leading to activation of caspase-9 and -3. Conclusions: Our results indicate that both BENDA and RIT participate in the induction of apoptosis of CLL lymphocytes in vitro in the presence of AS in the culture medium. The drug-induced apoptosis occurs mainly via intrinsic pathway and activation of P53 and PUMA proteins, however the extrinsic pathway is likely to be involved as well. We also found that the combination of these drugs induces the expression of P53, caspase-8 and -9 more potently than either of them used separately

Authors and Affiliations

Ewelina Ziolkowska, Dariusz Wolowiec, Barbara Cebula-Obrzut, Jerzy Z. Blonski, Piotr Smolewski, Tadeusz Robak, Anna Korycka-Wolowiec

Keywords

Related Articles

γH2AX in the recognition of DNA double-strand breaks

Double-strand breaks (DSBs) are highly deleterious DNA lesions because they can lead to chromosome aberrations or apoptosis. Various physical, chemical, and biological factors are involved in DSB induction. The formation...

The role of the Fanconi anemia pathway in DNA repair and maintenance of genome stability

The Fanconi anemia (FA) pathway is one of the DNA repair systems involved in removal of DNA crosslinks. Proteins which belong to this pathway are crucial to the protection of genetic information, whereas disturbances in...

Insulin resistance and chronic inflammation

Insulin resistance is a condition of reduced biological response to insulin. Growing evidence indicates the role of the chronic low-grade inflammatory response in the pathogenesis of insulin resistance. Adipose tissue in...

Inhibicja aktywności proteasomu jako nowa strategia w terapii i chemioprewencji nowotworów

System ubikwityna-proteasom jest jednym z głównych szlaków selektywnie degradujących białka komórkowe i regulujących większość procesów kluczowych dla zachowania homeostazy komórki. Degradacji proteasomalnej ulegają międ...

Download PDF file
  • EP ID EP67547
  • DOI -
  • Views 131
  • Downloads 0

How To Cite

Ewelina Ziolkowska, Dariusz Wolowiec, Barbara Cebula-Obrzut, Jerzy Z. Blonski, Piotr Smolewski, Tadeusz Robak, Anna Korycka-Wolowiec (2014). Cytotoxic and apoptosis-inducing effects of bendamustine used alone and in combination with rituximab on chronic lymphocytic leukemia cells in vitro. Advances in Hygiene and Experimental Medicine, 68(), 1433-1443. https://europub.co.uk/articles/-A-67547